NewAmsterdam Pharma Co N.V. Operating Margin in % from 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
NewAmsterdam Pharma Co N.V. quarterly/annual Operating Margin history and growth rate from 2022 to Q3 2025.
  • NewAmsterdam Pharma Co N.V. Operating Margin for the quarter ending September 30, 2025 was -576 %, a 5.05% decline year-over-year.
  • NewAmsterdam Pharma Co N.V. annual Operating Margin for 2024 was -387 %, a 70.2% increase from 2023.
  • NewAmsterdam Pharma Co N.V. annual Operating Margin for 2023 was -1.3K %, a 37391% decline from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

NewAmsterdam Pharma Co N.V. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -576 -27.7 -5.05% Jul 1, 2025 Sep 30, 2025
Q2 2025 -270 +2.54K +90.4% Apr 1, 2025 Jun 30, 2025
Q1 2025 -402 +2.49K +86.1% Jan 1, 2025 Mar 31, 2025
Q4 2024 -387 +912 +70.2% Oct 1, 2024 Dec 31, 2024
Q3 2024 -548 Jul 1, 2024 Sep 30, 2024
Q2 2024 -2.81K Apr 1, 2024 Jun 30, 2024
Q1 2024 -2.89K Jan 1, 2024 Mar 31, 2024
Q4 2023 -1.3K Oct 1, 2023 Dec 31, 2023

NewAmsterdam Pharma Co N.V. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -387 +912 +70.2% Jan 1, 2024 Dec 31, 2024
2023 -1.3K -1.3K -37391% Jan 1, 2023 Dec 31, 2023
2022 -3.46 Jan 1, 2022 Dec 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.